These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17350305)

  • 1. Evaluation of antimicrobial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa.
    Maiques JM; Doménech A; Cabellos C; Fernández A; Ribes S; Tubau F; Gudiol F; Viladrich PF
    Microbes Infect; 2007 Apr; 9(4):435-41. PubMed ID: 17350305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
    Hackbarth CJ; Chambers HF; Stella F; Shibl AM; Sande MA
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():65-9. PubMed ID: 3100492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy.
    Rodriguez WJ; Khan WN; Cocchetto DM; Feris J; Puig JR; Akram S
    Pediatr Infect Dis J; 1990 Feb; 9(2):83-7. PubMed ID: 2179845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y; Yu XH; Wang R; An MM; Liang BB
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime in the therapy of pseudomonal meningitis.
    Marone P; Concia E; Maserati R; Suter F; Minoli L; Andreoni M; Fiori G
    Chemioterapia; 1985 Aug; 4(4):289-92. PubMed ID: 3902257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.
    Zelenitsky SA; Iacovides H; Harding GK; Ariano RE
    Diagn Microbiol Infect Dis; 2004 May; 49(1):67-70. PubMed ID: 15135504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants.
    Tessin I; Trollfors B; Thiringer K; Thörn Z; Larsson P
    Eur J Pediatr; 1989 Jun; 148(7):679-81. PubMed ID: 2663518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response.
    Jacqueline C; Roquilly A; Desessard C; Boutoille D; Broquet A; Le Mabecque V; Amador G; Potel G; Caillon J; Asehnoune K
    J Antimicrob Chemother; 2013 Jan; 68(1):177-83. PubMed ID: 22941899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R; Fish DN; Obritsch MD; MacLaren R
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
    Zhanel GG; Mayer M; Laing N; Adam HJ
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2228-30. PubMed ID: 16723591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
    Louie A; Liu W; Liu QF; Sucke AC; Miller DA; Battles A; Miller MH
    Lab Anim Sci; 1997 Dec; 47(6):617-23. PubMed ID: 9433698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa.
    Moriarty F; Elborn S; Tunney M
    J Microbiol Methods; 2005 May; 61(2):171-9. PubMed ID: 15722142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.